Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (281-290 of 602) with videos related to

Pageof 61
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry studyChristian Brenneis, Sylvia M Boesch, Karl E Egger, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 17, 2014
A prospective questionnaire study in 100 healthy sleepers: non-bothersome forms of recognizable sleep disorders are still presentBirgit Frauscher, Thomas Mitterling, Aleke Bode, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2013
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Olivier Rascol, et al.
Parkinson'S Disease|February 28, 2020
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of LevodopaCindy Zadikoff, Werner Poewe, James T Boyd, et al.
European Journal of Neurology|July 9, 2023
Comparison of different risk scores for Parkinson disease in a population-based 10-year studyKathrin Marini, Klaus Seppi, Stefan Kiechl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2020
Automated Analysis of Diffusion-Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's DiseaseFlorian Krismer, Vincent Beliveau, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 14, 2018
Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year studyPhilipp Mahlknecht, Arno Gasperi, Atbin Djamshidian, et al.
Annals of Neurology|March 10, 2011
White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry studyChristoph Scherfler, Birgit Frauscher, Michael Schocke, et al.
Circulation|May 1, 2004
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular diseaseStefan Kiechl, Georg Schett, Gregor Wenning, et al.
Frontiers in Neuroscience|July 20, 2018
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of SynucleinopathyMartin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, et al.
Pageof 61

Showing results (281-290 of 602) with videos related to

Sort By:
Pageof 61
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry studyChristian Brenneis, Sylvia M Boesch, Karl E Egger, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 17, 2014
A prospective questionnaire study in 100 healthy sleepers: non-bothersome forms of recognizable sleep disorders are still presentBirgit Frauscher, Thomas Mitterling, Aleke Bode, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2013
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's diseaseC Warren Olanow, Karl Kieburtz, Olivier Rascol, et al.
Parkinson'S Disease|February 28, 2020
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of LevodopaCindy Zadikoff, Werner Poewe, James T Boyd, et al.
European Journal of Neurology|July 9, 2023
Comparison of different risk scores for Parkinson disease in a population-based 10-year studyKathrin Marini, Klaus Seppi, Stefan Kiechl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 16, 2020
Automated Analysis of Diffusion-Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's DiseaseFlorian Krismer, Vincent Beliveau, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 14, 2018
Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year studyPhilipp Mahlknecht, Arno Gasperi, Atbin Djamshidian, et al.
Annals of Neurology|March 10, 2011
White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry studyChristoph Scherfler, Birgit Frauscher, Michael Schocke, et al.
Circulation|May 1, 2004
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular diseaseStefan Kiechl, Georg Schett, Gregor Wenning, et al.
Frontiers in Neuroscience|July 20, 2018
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of SynucleinopathyMartin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, et al.
Pageof 61